Business Update
Boston Scientific now has two drug-eluting stents with European approval
Published in Cardiovascular Business Week, November 14th, 2006
This approval allows Boston Scientific to begin marketing the new DES in the 25 countries of the European Union and will support market registrations in other regulated countries in Asia, Latin America and Eastern Europe.
The Promus stent is a private-labeled Xience V Everolimus-Eluting Coronary stent system manufactured by Abbott and distributed by Boston Scientific. It will complement Boston...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
More Articles from Cardiovascular Business Week
- Arrhythmia Therapy
Research from Bico, Department of Statistics broadens understanding of arrhythmia therapy - Atherosclerosis
Reports summarize atherosclerosis research from Vascular Genetics Inc. - Atherosclerosis
Scientists at Cleveland Clinic Foundation, Department of Cardiovascular Medicine release new data on atherosclerosis - Atrial Fibrillation
CryoCath enrolls first patient in U.S. atrial fibrillation trial - Business & Finance
Hercules and Portola announce a $20 million financing agreement - Business Update
CardioWest temporary Total Artificial Heart adopted by top transplant centers - More from this issue of Cardiovascular Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
